Kennedy Capital Management Increases Stake in Health Catalyst by 42.7%

Summary

Kennedy Capital Management increased its holding in Health Catalyst, Inc. (NASDAQ: HCAT) by 42.7% during the fourth quarter of 2023, now owning 1,891,000 shares worth $13.37 million. Other investors like Impax Asset Management and Geode Capital also increased their holdings. Health Catalyst’s stock opened at $4.02, with a market cap of $282.25 million. Analysts’ ratings are mixed, with a general rating of ‘Moderate Buy’ and a target price of $8.73. Recent insider trading includes COO Daniel Lesueur selling shares at an average price of $4.52.Market Beat Piper Sandler lowered Health Catalyst’s target price from $12.00 to $8.00 in February and gave the stock an ‘Overweight’ rating.Market Beat

Impact Analysis

The event is classified at the company level, focusing on Health Catalyst. Kennedy Capital Management’s significant increase in holdings suggests confidence in the company’s future performance, which could positively influence investor sentiment and potentially boost the stock price. Other institutional investors like Impax Asset Management and Geode Capital also bolstered their positions, reinforcing this sentiment.Market Beat+ 2 Piper Sandler’s recent rating adjustment lowers the target price to $8.00, indicating cautious optimism.Market Beat The mixed analyst ratings and insider selling by COO Daniel Lesueur add layers of complexity to the stock’s outlook, presenting both opportunities and risks. Investors might consider Health Catalyst as a potential buy opportunity given the current undervaluation relative to analyst targets, but should also weigh the risks of fluctuating stock prices and insider trading activities.Market Beat